Alison T Stopeck

  • 10991 Citations
  • 41 h-Index
1982 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Article
14 Scopus citations
11 Scopus citations

Advances in the biological therapy and gene therapy of malignant disease

Hersh, E. M. & Stopeck, A. T., Dec 1997, In : Clinical Cancer Research. 3, 12 II, p. 2623-2629 7 p.

Research output: Contribution to journalArticle

30 Scopus citations

A maximum-likelihood method to estimate a single ADC value of lesions using diffusion MRI

Jha, A. K., Rodriguez, J. J. & Stopeck, A. T., 2016, (Accepted/In press) In : Magnetic Resonance in Medicine.

Research output: Contribution to journalArticle

4 Scopus citations

Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast

Coronella, J. A., Perry, C. S., Welch, M., Trevor, K. T., Stopeck, A. T., Villar, H. & Hersh, E. M., Aug 15 2002, In : Journal of Immunology. 169, 4, p. 1829-1836 8 p.

Research output: Contribution to journalArticle

105 Scopus citations

A phase 1 trial of 2 dose schedules of ABT-510, an antiangiogenic, thrombospondin-1-mimetic peptide, in patients with advanced cancer

Gordon, M. S., Mendelson, D., Carr, R., Knight, R. A., Humerickhouse, R. A., Iannone, M. E. & Stopeck, A. T., Dec 15 2008, In : Cancer. 113, 12, p. 3420-3429 10 p.

Research output: Contribution to journalArticle

21 Scopus citations
45 Scopus citations

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Chalasani, P., Marron, M., Roe, D., Clarke, K., Iannone, M. E., Livingston, R. B., Shan, J. S. & Stopeck, A. T., Jul 1 2015, In : Cancer Medicine. 4, 7, p. 1051-1059 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer

Segar, J. M., Reed, D., Stopeck, A. T., Livingston, R. B. & Chalasani, P., Jan 1 2019, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Open Access

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

Rugo, H. S., Jo Chien, A., Franco, S. X., Stopeck, A. T., Glencer, A., Lahiri, S., Arbushites, M. C., Scott, J., Park, J. W., Hudis, C., Nulsen, B. & Dickler, M. N., Jul 2012, In : Breast Cancer Research and Treatment. 134, 1, p. 13-20 8 p.

Research output: Contribution to journalArticle

31 Scopus citations

A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108

Stopeck, A. T., Unger, J. M., Rimsza, L. M., Bellamy, W. T., Iannone, M. E., Persky, D., Leblanc, M., Fisher, R. & Miller, T. P., 2009, In : Leukemia and Lymphoma. 50, 5, p. 728-735 8 p.

Research output: Contribution to journalArticle

82 Scopus citations
11 Scopus citations

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen

Thomson, C., Chow, H-H., Wertheim, B. C., Roe, D., Stopeck, A. T., Maskarinec, G., Altbach, M. I., Chalasani, P., Huang, C., Strom, M. B., Galons, J-P. & Thompson, P. A., May 30 2017, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-11 11 p.

Research output: Contribution to journalArticle

8 Scopus citations

Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models

Chen, L. Q., Howison, C. M., Perry, C. S., Stopeck, A. T., Malm, S. W., Pagel, M. M. & Baker, A. F., May 1 2015, In : Leukemia and Lymphoma. 56, 5, p. 1432-1439 8 p.

Research output: Contribution to journalArticle

18 Scopus citations

Authors' response to letter to the editor.

Stopeck, A. T., Henry, D., Dansey, R., Qian, Y., Cong, Z. & Arellano, J., 2013, In : Journal of Medical Economics. 16, 2, p. 262-263 2 p.

Research output: Contribution to journalArticle

Automated Breast Segmentation of Fat and Water MR Images Using Dynamic Programming

Rosado-Toro, J. A., Barr, T., Galons, J-P., Marron, M. T., Stopeck, A. T., Thomson, C., Thompson, P., Carroll, D., Wolf, E., Altbach, M. I. & Rodriguez, J. J., Feb 1 2015, In : Academic Radiology. 22, 2, p. 139-148 10 p.

Research output: Contribution to journalArticle

25 Scopus citations

Bone-related complications and quality of life in advanced breast cancer: Results from a randomized phase III trial of denosumab versus zoledronic acid

Martin, M., Bell, R., Bourgeois, H., Brufsky, A., Diel, I., Eniu, A., Fallowfield, L., Fujiwara, Y., Jassem, J., Paterson, A. H. G., Ritchie, D., Steger, G. G., Stopeck, A. T., Vogel, C., Fan, M., Jiang, Q., Chung, K., Dansey, R. & Braun, A., Sep 1 2012, In : Clinical Cancer Research. 18, 17, p. 4841-4849 9 p.

Research output: Contribution to journalArticle

65 Scopus citations

Caring for the Breast Cancer Survivor: A Guide for Primary Care Physicians

Chalasani, P., Downey, L. & Stopeck, A. T., Jun 2010, In : American Journal of Medicine. 123, 6, p. 489-495 7 p.

Research output: Contribution to journalArticle

24 Scopus citations

Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft

Clark, P. R., Stopeck, A. T., Parker, S. E. & Hersh, E. M., Sep 15 2000, In : Cellular Immunology. 204, 2, p. 96-104 9 p.

Research output: Contribution to journalArticle

5 Scopus citations

Changes in body weight and metabolic indexes in overweight breast cancer survivors enrolled in a randomized trial of low-fat vs. reduced carbohydrate diets

Thomson, C., Stopeck, A. T., Bea, J. W., Cussler, E., Nardi, E., Frey, G. & Thompson, P. A., Nov 2010, In : Nutrition and Cancer. 62, 8, p. 1142-1152 11 p.

Research output: Contribution to journalArticle

43 Scopus citations

Changes in bone turnover marker levels and clinical outcomes in patients with advanced cancer and bone metastases treated with bone antiresorptive agents

Lipton, A., Smith, M. R., Fizazi, K., Stopeck, A. T., Henry, D., Brown, J. E., Shore, N. D., Saad, F., Spencer, A., Zhu, L. & Warner, D. J., Dec 1 2016, In : Clinical Cancer Research. 22, 23, p. 5713-5721 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

Theilmann, R. J., Borders, R., Trouard, T. P., Xia, G., Outwater, E., Ranger-Moore, J., Gillies, R. J. & Stopeck, A. T., Nov 2004, In : Neoplasia. 6, 6, p. 831-837 7 p.

Research output: Contribution to journalArticle

209 Scopus citations

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer

Brown-Glaberman, U., Marron, M., Chalasani, P., Livingston, R. B., Iannone, M. E., Specht, J. & Stopeck, A. T., 2016, In : Disease Markers. 2016, 9810383.

Research output: Contribution to journalArticle

7 Scopus citations

Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer

Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A. T., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., Fritsche, H. A., Hortobagyi, G. N. & Terstappen, L. W. M. M., 2005, In : Journal of Clinical Oncology. 23, 7, p. 1420-1430 11 p.

Research output: Contribution to journalArticle

791 Scopus citations

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. T., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M. & Hayes, D. F., Aug 19 2004, In : New England Journal of Medicine. 351, 8, p. 781-791 11 p.

Research output: Contribution to journalArticle

2913 Scopus citations

Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival.

Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. T., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V. & Terstappen, L. W. W. M., Jul 15 2006, In : Clinical Cancer Research. 12, 14 Pt 1, p. 4218-4224 7 p.

Research output: Contribution to journalArticle

686 Scopus citations

Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer

Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A. T., Borden, E., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M. & Hayes, D. F., Nov 1 2006, In : Clinical Cancer Research. 12, 21, p. 6403-6409 7 p.

Research output: Contribution to journalArticle

554 Scopus citations

Combination of trastuzumab and tanespimycin (17-AAG, KOS-953) is safe and active in trastuzumab-refractory HER-2-overexpressing breast cancer: A phase I dose-escalation study

Modi, S., Stopeck, A. T., Gordon, M. S., Mendelson, D., Solit, D. B., Bagatell, R., Ma, W., Wheler, J., Rosen, N., Norton, L., Cropp, G. F., Johnson, R. G., Hannah, A. L. & Hudis, C. A., Dec 1 2007, In : Journal of Clinical Oncology. 25, 34, p. 5410-5417 8 p.

Research output: Contribution to journalArticle

285 Scopus citations

Construction of new amplifier expression vectors for high levels of IL-2 gene expression.

Tsang, T. C., Brailey, J. L., Vasanwala, F. H., Wu, R. S., Liu, F., Clark, P. R., Meade-Tollin, L., Luznick, L., Stopeck, A. T., Akporiaye, E. T. & Harris, D. T., Mar 2000, In : International Journal of Molecular Medicine. 5, 3, p. 295-300 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

Cost-effectiveness of denosumab for the prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A. T., Brufsky, A., Kennedy, L., Bhatta, S., Bhowmik, D., Buchanan, J., Despiegel, N. & Hechmati, G., Jan 1 2019, (Accepted/In press) In : Journal of medical economics.

Research output: Contribution to journalArticle

Open Access

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

Stopeck, A. T., Rader, M., Henry, D., Danese, M., Halperin, M., Cong, Z., Qian, Y., Dansey, R. & Chung, K., Aug 2012, In : Journal of Medical Economics. 15, 4, p. 712-723 12 p.

Research output: Contribution to journalArticle

43 Scopus citations

Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells

Stopeck, A. T., Nicholson, A. C., Mancini, F. P. & Hajjar, D. P., Aug 15 1993, In : Journal of Biological Chemistry. 268, 23, p. 17489-17494 6 p.

Research output: Contribution to journalArticle

121 Scopus citations

Decreased bone mineral density in adult patients with Hemophilia: Clinical significance, prevalence and risk factors

Broum-Glaberman, U., Kissee, M. C., Damiano, M. L., Roe, D. & Stopeck, A. T., Oct 2011, In : Journal of Coagulation Disorders. 3, 1, p. 27-33 7 p.

Research output: Contribution to journalArticle

1 Scopus citations

Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: A randomized, double-blind study

Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., De Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., Dansey, R., Jun, S. & Braun, A., Dec 10 2010, In : Journal of Clinical Oncology. 28, 35, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

978 Scopus citations

Diagnosing and treating breast cancer in elderly women: A call for improved understanding

Downey, L., Livingston, R. B. & Stopeck, A. T., Oct 2007, In : Journal of the American Geriatrics Society. 55, 10, p. 1636-1644 9 p.

Research output: Contribution to journalArticle

21 Scopus citations

Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis

Stephen, R. M., Jha, A. K., Roe, D. J., Trouard, T. P., Galons, J. P., Kupinski, M. A., Frey, G., Cui, H., Squire, S., Pagel, M. M., Rodriguez, J. J., Gillies, R. J. & Stopeck, A. T., Dec 1 2015, In : Magnetic Resonance Imaging. 33, 10, p. 1267-1273 7 p.

Research output: Contribution to journalArticle

8 Scopus citations

Dominant thalassemia-like phenotypes associated with mutations in exon 3 of the β-globin gene

Kazazian, H. H., Dowling, C. E., Hurwitz, R. L., Coleman, M., Stopeck, A. T. & Adams, J. G., Jun 1 1992, In : Blood. 79, 11, p. 3014-3018 5 p.

Research output: Contribution to journalArticle

61 Scopus citations

Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics

Lipton, A., Fizazi, K., Stopeck, A. T., Henry, D. H., Smith, M. R., Shore, N., Martin, M., Vadhan-Raj, S., Brown, J. E., Richardson, G. E., Saad, F., Yardley, D. A., Zhou, K., Balakumaran, A. & Braun, A., Jan 1 2016, In : European Journal of Cancer. 53, p. 75-83 9 p.

Research output: Contribution to journalArticle

47 Scopus citations

Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia

O'Farrell, A. M., Yuen, H. A., Smolich, B., Hannah, A. L., Louie, S. G., Hong, W., Stopeck, A. T., Silverman, L. R., Lancet, J. E., Karp, J. E., Albitar, M., Cherrington, J. M. & Giles, F. J., Jul 2004, In : Leukemia Research. 28, 7, p. 679-689 11 p.

Research output: Contribution to journalArticle

68 Scopus citations

EMERGE: A randomized phase II study of the antibody-drug conjugate glembatumumab vedotin in advanced glycoprotein NMB - Expressing breast cancer

Yardley, D. A., Weaver, R., Melisko, M. E., Saleh, M. N., Arena, F. P., Forero, A., Cigler, T., Stopeck, A. T., Citrin, D., Oliff, I., Bechhold, R., Loutfi, R., Garcia, A. A., Cruickshank, S., Crowley, E., Green, J., Hawthorne, T., Yellin, M. J., Davis, T. A. & Vahdat, L. T., May 10 2015, In : Journal of Clinical Oncology. 33, 14, p. 1609-1619 11 p.

Research output: Contribution to journalArticle

79 Scopus citations

Erratum: A chilling tale (American Journal of Medicine (2005) 118 (1108-1110))

Stopeck, A. T., Feb 2006, In : American Journal of Medicine. 119, 2, p. 191 1 p.

Research output: Contribution to journalArticle

Erratum to: Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: Integrated results from three randomized, double-blind studies of denosumab and zoledronic acid (Support Care Cancer (2013) 21, (3497-3507) DOI: 10.1007/s00520-013-1932-2)

Von Moos, R., Body, J. J., Egerdie, B., Stopeck, A. T., Brown, J. E., Damyanov, D., Fallowfield, L. J., Marx, G., Cleeland, C. S., Patrick, D. L., Palazzo, F. G., Qian, Y., Braun, A. & Chung, K., 2014, In : Supportive Care in Cancer. 22, 8, p. 2309-2310 2 p.

Research output: Contribution to journalArticle

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer [Supportive Care in Cancer, (2015), DOI:10.1007/s00520-015-2904-5]

Stopeck, A. T., Fizazi, K., Body, J. J., Brown, J. E., Carducci, M., Diel, I., Fujiwara, Y., Martín, M., Paterson, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J. & Braun, A., Jan 1 2016, In : Supportive Care in Cancer. 24, 1, p. 457-458 2 p.

Research output: Contribution to journalArticle

17 Scopus citations

Extending aromatase-inhibitor adjuvant therapy to 10 years

Goss, P. E., Ingle, J. N., Pritchard, K. I., Robert, N. J., Muss, H., Gralow, J., Gelmon, K., Whelan, T., Strasser-Weippl, K., Rubin, S., Sturtz, K., Wolff, A. C., Winer, E., Hudis, C., Stopeck, A. T., Beck, J. T., Kaur, J. S., Whelan, K., Tu, D. & Parulekar, W. R., Jul 21 2016, In : New England Journal of Medicine. 375, 3, p. 209-219 11 p.

Research output: Contribution to journalArticle

252 Scopus citations

Hepatic injury associated with bevacizumab use in metastatic breast and colon cancers: A review of two cases

Brown-Glaberman, U., Swart, R., Dragovich, T., Bracamonte, E., Kurtin, S. & Stopeck, A. T., Oct 2008, In : Community Oncology. 5, 10, p. 539-542 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

HIV/AIDS case histories: Diagnostic problems

Snyder, L. S., Stopeck, A. T. & Godwin, J. H., 1997, In : AIDS Patient Care and STDs. 11, 4, p. 285-286 2 p.

Research output: Contribution to journalArticle

How do we define efficacy in comparing osteoclast-targeted agents in metastatic breast cancer?

Gralow, J. R., Lipton, A. & Stopeck, A. T., Sep 10 2011, In : Journal of Clinical Oncology. 29, 26, p. 3591-3592 2 p.

Research output: Contribution to journalArticle

2 Scopus citations

HSP90 inhibition is effective in breast cancer: A phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab

Modi, S., Stopeck, A. T., Linden, H., Solit, D., Chandarlapaty, S., Rosen, N., D'Andrea, G., Dickler, M., Moynahan, M. E., Sugarman, S., Ma, W., Patil, S., Norton, L., Hannah, A. L. & Hudis, C., Aug 1 2011, In : Clinical Cancer Research. 17, 15, p. 5132-5139 8 p.

Research output: Contribution to journalArticle

287 Scopus citations